Is CD36 p.Pro191= (c.573G>A) pathogenic?

CD36 p.Pro191= (c.573G>A) is classified Conflicting classifications of pathogenicity in CD36 (ClinVar, Conflicting submitters, 2 submitters; last evaluated 2021-06-09). Low-frequency (popmax 2.78%, nfe); Associated with platelet-type bleeding disorder 10.

What condition is associated with CD36 p.Pro191= (c.573G>A)?

CD36 p.Pro191= (c.573G>A) is associated with platelet-type bleeding disorder 10 (ClinVar).

How common is CD36 p.Pro191= (c.573G>A) in the general population?

CD36 p.Pro191= (c.573G>A) is low-frequency (popmax 2.78%, nfe) (gnomAD).

CD36 p.Pro191=

c.573G>A · rs5956 · VCV910697

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 2 submitters

gnomAD v4.1

Rare

low-frequency (popmax 2.78%, nfe)

Conditions

platelet-type bleeding disorder 10

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -1.1	GERP -2.3
Overall
CADD	7.798	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 2.78% European (non-Finnish) · 32,822/1,179,272 alleles

Filtering AF 2.76% ClinGen BA1/BS1 input FAF95, joint · FAF99 2.75%

Overall 2.39% 38,605/1,613,100 alleles · low-frequency

Ancestry group	Frequency	1 in
Finnishnot grpmax-eligible	5.26%	19
European (non-Finnish)grpmax	2.78%	36
Remaining individualsnot grpmax-eligible	1.76%	57
Amishnot grpmax-eligible	1.65%	61
Ashkenazi Jewishnot grpmax-eligible	0.866%	116
Admixed American	0.57%	175
African / African-American	0.417%	240
Middle Eastern	0.413%	242
South Asian	0.397%	252
East Asian	0.00447%	22,386

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CD36
Protein: p.Pro191=
Coding: c.573G>A
MANE Select: NM_001001548
dbSNP: rs5956
Type: single nucleotide variant
Location: chr7:80663133 (GRCh38)
Gene constraint: LOEUF 1.953 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure: AlphaFold pLDDT 94.14 · 1 PDB

Full CD36 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

platelet-type bleeding disorder 10 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

CD36 p.Pro191Leu Uncertain significance ★★ ⚠ same residue
CD36 c.1254+1G>A Likely pathogenic ★★ same condition
CD36 c.430-2A>G Likely pathogenic ★★ same condition
CD36 p.Cys243Ter Pathogenic ★★ same condition
CD36 p.Leu381Ter Pathogenic/Likely pathogenic ★★ same condition
CD36 p.Tyr62Ter Likely pathogenic ★★ same condition
CD36 c.-27C>T Uncertain significance ★★ same condition
CD36 p.Ala427Ser Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd36-p-pro191 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown